Literature DB >> 13533726

Infectivity to mosquitoes of Plasmodium vivax following treatment with chloroquine and other antimalarials.

G M JEFFERY.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/effects

Mesh：

Substances：

Year:  1958        PMID： 13533726     DOI： 10.4269/ajtmh.1958.7.207

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  9 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 2.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 3.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.

Authors:  Abdoul H Beavogui; Abdoulaye A Djimde; Aric Gregson; Abdoulaye M Toure; Adama Dao; Boubacar Coulibaly; Dinkorma Ouologuem; Bakary Fofana; Adama Sacko; Mamadou Tekete; Aminatou Kone; Oumou Niare; Mamadou Wele; Christopher V Plowe; Stephane Picot; Ogobara K Doumbo
Journal:  Int J Parasitol       Date:  2010-05-09       Impact factor: 3.981

5.  Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival.

Authors:  Aminatou Kone; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Geert-Jan van Gemert; Antoine Dara; Hamidou Niangaly; Adrian Luty; Ogobara K Doumbo; Robert Sauerwein; Abdoulaye A Djimde
Journal:  Int J Parasitol       Date:  2010-06-02       Impact factor: 3.981

6.  A simulation model of the within-host dynamics of Plasmodium vivax infection.

Authors:  Douglas H Kerlin; Michelle L Gatton
Journal:  Malar J       Date:  2015-02-05       Impact factor: 2.979

7.  Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.

Authors:  Andre M Siqueira; Aline C Alencar; Gisely C Melo; Belisa L Magalhaes; Kim Machado; Aristóteles C Alencar Filho; Andrea Kuehn; Marly M Marques; Monica Costa Manso; Ingrid Felger; José L F Vieira; Valerie Lameyre; Claudio T Daniel-Ribeiro; Marcus V G Lacerda
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

8.  Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

Authors:  Nicholas M Douglas; Julie A Simpson; Aung Pyae Phyo; Hadjar Siswantoro; Armedy R Hasugian; Enny Kenangalem; Jeanne Rini Poespoprodjo; Pratap Singhasivanon; Nicholas M Anstey; Nicholas J White; Emiliana Tjitra; Francois Nosten; Ric N Price
Journal:  J Infect Dis       Date:  2013-06-12       Impact factor: 5.226

9.  Tafenoquine for travelers' malaria: evidence, rationale and recommendations.

Authors:  J Kevin Baird
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.